// App-Quantinova.ai

653 : JAK Inhibitors Counteract Cellular Toxicity of Hydroxychloroquine in Vitro

Researchers

Presenter

  • Hiroshi Kajiyama

Principal Investigators

  • Yoshimi Aizaki

  • Hiroaki Yazawa

  • Kazuhiro Yokota

  • Yasuto Araki

  • Yuji Akiyama

  • Toshihide Mimura

Medical Centers

  • Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Saitama, Japan

  • Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Saitama, Japan

  • Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Saitama, Japan

  • Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Saitama, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Endocrine/metabolic Diseases (ME)

Disease

  • Diabetic retinopathy

  • Renal disease

Biomarkers

  • Janus kinase

Drug/Treatment

  • Hydroxychloroquine

  • ABT-494

  • Baricitinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved